Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-29 Sale |
2023-10-05 5:16 pm |
Celularity Inc | CELU | Sorrento Therapeutics Inc. 10% Owner |
15,371,697 | $0 | $0 | 5,050,427 (Direct) |
View |
| 2023-09-21 Sale |
2023-09-25 4:27 pm |
Scilex Holding Co | SCLX | Sorrento Therapeutics Inc. 10% Owner |
60,068,585 | $0 | $0 | 1,917,210 (Direct) |
View |
| 2021-03-15 Sale |
2023-02-06 9:10 pm |
Sorrento Therapeutics Inc. | SRNE | Janda Kim Director |
3,000 | $10.42 | $31,273 | 0 (Direct) |
View |
| 2022-09-07 Purchase |
2022-09-07 6:22 pm |
Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks |
88,888 | $2.0177 | $179,349 | 7,078,386 (Indirect Direct) |
View |
| 2022-09-06 Purchase |
2022-09-06 5:24 pm |
Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks |
55,555 | $1.9599 | $108,882 | 6,988,610 (Indirect Direct) |
View |
| 2022-08-26 Purchase |
2022-08-26 5:33 pm |
Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks |
33,333 | $2.11 | $70,333 | 4,433,255 (Indirect Direct) |
View |
| 2022-08-25 Purchase |
2022-08-25 5:18 pm |
Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks |
22,222 | $2.0596 | $45,768 | 4,400,722 (Indirect Direct) |
View |
| 2022-06-14 Purchase |
2022-06-14 5:15 pm |
Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks |
10,000 | $1.3999 | $13,999 | 4,377,500 (Indirect Direct) |
View |
| 2021-12-27 Sale |
2021-12-27 7:34 pm |
Sorrento Therapeutics Inc. | SRNE | Janda Kim Director |
3,000 | $5.88 | $17,640 | 3,000 (Direct) |
View |
| 2021-09-27 Sale |
2021-09-28 5:37 pm |
Sorrento Therapeutics Inc. | SRNE | Janda Kim Director |
42,357 | $8.0204 | $339,720 | 30,643 (Direct) |
View |
| 2021-09-13 Sale |
2021-09-14 5:00 pm |
Sorrento Therapeutics Inc. | SRNE | Janda Kim Director |
8,000 | $8.0356 | $64,285 | 3,000 (Direct) |
View |
| 2021-04-12 Sale |
2021-04-15 6:43 pm |
Sorrento Therapeutics Inc. | SRNE | Janda Kim Director |
1,900 | $6.9742 | $13,251 | 3,000 (Direct) |
View |
| 2020-12-16 Sale |
2021-01-26 5:24 pm |
Sorrento Therapeutics Inc. | SRNE | Followwill Dorman Director |
1,000 | $7.135 | $7,135 | 2,130 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-17 Exercise |
2023-03-20 7:52 pm |
N/A N/A |
Sorrento Therapeutics Inc. | SRNEQ | Ji Henry See Remarks |
19,500 | $0.8027 | 8,597,498 (Indirect) |
View |
| 2023-01-19 Other |
2023-01-23 4:11 pm |
N/A N/A |
Scilex Holding Co | SCLX | Sorrento Therapeutics Inc. 10% Owner |
73,740,795 | $0 | 135,726,590 (Direct) |
View |
| 2022-12-02 Exercise |
2022-12-23 2:28 pm |
N/A N/A |
Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks |
500 | $5.5 | 8,578,391 (Indirect) |
View |
| 2022-12-02 Exercise |
2022-12-23 2:28 pm |
2022-08-26 2023-03-17 |
Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks |
5 | $0 | 8,578,391 (Indirect) |
View |
| 2022-12-15 Option Award |
2022-12-16 8:10 pm |
N/A N/A |
Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks |
1,500,000 | $0 | 8,577,498 (Direct) |
View |
| 2022-11-10 Other |
2022-11-15 6:38 pm |
2022-11-10 2027-11-10 |
Vickers Vantage Corp. I | SCLX | Sorrento Therapeutics Inc. 10% Owner |
3,104,000 | $0 | 5,900,704 (Direct) |
View |
Ownership |
2022-11-15 6:27 pm |
N/A N/A |
Vickers Vantage Corp. I | SCLX | Sorrento Therapeutics Inc. 10% Owner |
0 | $0 | 164,783,687 (Direct) |
View |
| 2022-09-02 Option Award |
2022-09-02 4:31 pm |
N/A N/A |
Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks |
2,500,000 | $0 | 6,933,055 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 5:14 pm |
N/A 2032-05-18 |
Sorrento Therapeutics Inc. | SRNE | CZEREPAK ELIZABETH EVP & Chief Financial Officer |
350,000 | $0 | 350,000 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 5:11 pm |
N/A 2032-05-18 |
Sorrento Therapeutics Inc. | SRNE | Reilly Tammy Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-12-27 Exercise |
2021-12-27 7:34 pm |
2013-01-01 2022-02-06 |
Sorrento Therapeutics Inc. | SRNE | Janda Kim Director |
3,000 | $0 | 3,000 (Direct) |
View |
| 2021-12-27 Exercise |
2021-12-27 7:34 pm |
N/A N/A |
Sorrento Therapeutics Inc. | SRNE | Janda Kim Director |
3,000 | $4 | 3,000 (Direct) |
View |
| 2021-11-18 Option Award |
2021-11-18 5:11 pm |
N/A 2031-11-18 |
Sorrento Therapeutics Inc. | SRNE | CZEREPAK ELIZABETH Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-09-29 Exercise |
2021-09-29 2:35 pm |
N/A 2022-02-06 |
Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks |
10,000 | $0 | 4,367,500 (Direct) |
View |
| 2021-09-29 Exercise |
2021-09-29 2:35 pm |
N/A N/A |
Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks |
10,000 | $4 | 4,367,500 (Direct) |
View |
| 2021-09-27 Exercise |
2021-09-28 5:37 pm |
N/A 2027-09-15 |
Sorrento Therapeutics Inc. | SRNE | Janda Kim Director |
42,357 | $0 | 30,643 (Direct) |
View |
| 2021-09-27 Exercise |
2021-09-28 5:37 pm |
N/A N/A |
Sorrento Therapeutics Inc. | SRNE | Janda Kim Director |
7,357 | $3.57 | 30,643 (Direct) |
View |
| 2021-09-27 Exercise |
2021-09-28 5:37 pm |
N/A N/A |
Sorrento Therapeutics Inc. | SRNE | Janda Kim Director |
35,000 | $1.8 | 30,643 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-14 5:00 pm |
N/A 2021-09-28 |
Sorrento Therapeutics Inc. | SRNE | Janda Kim Director |
8,000 | $0 | 3,000 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-14 5:00 pm |
N/A N/A |
Sorrento Therapeutics Inc. | SRNE | Janda Kim Director |
8,000 | $3.5 | 3,000 (Direct) |
View |
| 2021-09-03 Exercise |
2021-09-03 5:36 pm |
N/A 2029-12-16 |
Sorrento Therapeutics Inc. | SRNE | Smith Robin L Director |
175,000 | $0 | 235,000 (Direct) |
View |
| 2021-09-03 Exercise |
2021-09-03 5:36 pm |
N/A N/A |
Sorrento Therapeutics Inc. | SRNE | Smith Robin L Director |
75,000 | $3.95 | 235,000 (Direct) |
View |
| 2021-09-03 Exercise |
2021-09-03 5:36 pm |
N/A N/A |
Sorrento Therapeutics Inc. | SRNE | Smith Robin L Director |
100,000 | $4.89 | 235,000 (Direct) |
View |
| 2021-08-30 Option Award |
2021-08-30 8:16 pm |
N/A 2031-08-30 |
Sorrento Therapeutics Inc. | SRNE | Ji Henry See Remarks |
2,500,000 | $0 | 2,500,000 (Direct) |
View |
| 2021-08-30 Option Award |
2021-08-30 8:16 pm |
N/A 2031-08-30 |
Sorrento Therapeutics Inc. | SRNE | Wu Yue Alexander Director |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-08-30 Option Award |
2021-08-30 8:15 pm |
N/A 2031-08-30 |
Sorrento Therapeutics Inc. | SRNE | Smith Robin L Director |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-08-30 Option Award |
2021-08-30 8:14 pm |
N/A 2031-08-30 |
Sorrento Therapeutics Inc. | SRNE | SHAH JAISIM Director |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-08-30 Option Award |
2021-08-30 8:13 pm |
N/A 2031-08-30 |
Sorrento Therapeutics Inc. | SRNE | Lemus David Director |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-08-30 Option Award |
2021-08-30 8:13 pm |
N/A 2031-08-30 |
Sorrento Therapeutics Inc. | SRNE | Janda Kim Director |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-08-30 Option Award |
2021-08-30 8:12 pm |
N/A 2031-08-30 |
Sorrento Therapeutics Inc. | SRNE | Followwill Dorman Director |
250,000 | $0 | 250,000 (Direct) |
View |
Ownership |
2021-07-23 06:04 am |
N/A N/A |
Celularity Inc | CELU | Sorrento Therapeutics Inc. 10% Owner |
0 | $0 | 20,422,124 (Direct) |
View |
| 2021-04-12 Exercise |
2021-04-15 6:43 pm |
2012-04-15 2021-04-15 |
Sorrento Therapeutics Inc. | SRNE | Janda Kim Director |
1,900 | $0 | 3,000 (Direct) |
View |
| 2021-04-12 Exercise |
2021-04-15 6:43 pm |
N/A N/A |
Sorrento Therapeutics Inc. | SRNE | Janda Kim Director |
1,900 | $3.5 | 3,000 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-17 4:57 pm |
N/A 2031-03-16 |
Sorrento Therapeutics Inc. | SRNE | Asghar Najjam Chief Financial Officer |
156,974 | $0 | 156,974 (Direct) |
View |
| 2020-11-11 Acquisition |
2021-01-26 5:24 pm |
N/A N/A |
Sorrento Therapeutics Inc. | SRNE | Followwill Dorman Director |
1,000 | $0 | 2,130 (Direct) |
View |